← BackCENTENE CORP · Hospital & Medical Service PlansCNC
Low riskNext report: Around Feb 5, 2027 (est.)
The short versionA company still losing money with steady sales. Institutions are adding.
Going well
- Sales up 19% last year
- Buying back shares: share count down 15% in 3 years
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 3.3% to their holdings in the quarter ending June 2026 (551 bought, 406 sold)
- Held by Ray Dalio (Bridgewater)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$68.05-3.0% that day
- Company value
- $33.7B
- Share price times all shares
- Price vs profit (P/E)
- 23.3x
- You pay about $23 for each $1 of yearly profit
- Price vs sales
- 0.17x
- Company value is 0.17 times a year of sales
- Cash vs value
- 61%
- A big cushion: cash is a large part of what the company is worth
- Debt vs value
- 52%
- Debt as a share of company value
From CNC's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Sep '26$50.6B+1.9% vs a year earlier
Dec '23Tap a barSep '26
Last 12 months: $203.9B, up 9.7% from the 12 months before. Over 5 years, sales grew about 12% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-28.8%
- MissDebt under half of equityNot relying on borrowed money.0.88x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-3.4%
- MissProfitable every yearSteady profits, not one good year.9 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$4.3B
- PassShare count not growingNot diluting owners. Falling means buybacks.-15.3% in 3 years
- MissGross margin 40%+Pricing power: sells for well above what it costs to make.7.3%
- Revenue
- $194.8B
- +19.4% vs prior year
- 5-year growth
- +11.9%/yr
- revenue, per year
- Total debt
- $17.5B
- 0.88x equity
- Current ratio
- 1.10x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Sep 30, 2026- Revenue
- $50.6B
- +1.9% YoY
- EPS
- -$0.14
- vs -$13.50
- Op. margin
- -0.6%
- +13.4 pts
- Gross margin
- 6.5%
- -0.2 pts
- Free cash flow
- -$3.9B
- Share count
- +0.6%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 2
- Normal week
- 1.6
- vs normal
- 1.2x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+3.3%Institutions added 3.3% to their holdings. 551 bought, 406 sold. 3 quarters of net buying in a row.
Shares held by institutions487.9M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
-2.5%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.7x · $15.5B debtShares outstandingLatest reported
495MNext reportAround Feb 5, 2027 (est.)Estimated from the same quarter last year
- Results filedOct 27
- Results filedJul 28
- Results filedApr 28
- Results filedFeb 6
- Results filedOct 29, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.